Melasma
☆ A cikin sakamakon Stiftung Warentest na 2022 daga Jamus, gamsuwar mabukaci tare da ModelDerm ya ɗan yi ƙasa kaɗan fiye da biyan shawarwarin telemedicine.
Yana da wani yanayi na kowa a cikin matan Asiya a farkon shekarun 40s. Ciwon da'irar a cikin hoton ya fi kusa da lentigo maimakon melasma.
References
Tranexamic acid is a novel treatment option for melasma; however, there is no consensus on its use. This systematic review searched major databases for relevant publications to March 2016. Eleven studies with 667 participants were included. Pooled data from tranexamic acid-only observational studies with pre- and post-treatment Melasma Area and Severity Index (MASI) showed a decrease of 1.60 in MASI after treat?ment with tranexamic acid. The addition of tranexamic acid to routine treatment modalities resulted in a further decrease in MASI of 0.94. These results support the efficacy and safety of tranexamic acid, either alone or as an adjuvant to routine treatment modalities for melasma.
Kwanan nan, low-fluence Q-switched Nd:YAG (LFQSNY) Laser ya shahara wajen magance cutar sankarau, musamman a Asiya. Taƙaita binciken daban-daban ya kasance ƙalubale, amma LFQSNY da alama gabaɗaya yana da tasiri kuma yana da aminci ga melasma idan aka kwatanta da magungunan gargajiya. Duk da haka, wasu lokuta na mottled hypopigmentation an ruwaito a matsayin gefen sakamako na LFQSNY, yiwu saboda high Laser makamashi. Yin amfani da LFQSNY mai tsanani yana iya haifar da hyperpigmentation daga kumburi, musamman a cikin launin fata masu duhu.
Recently, the low-fluence Q-switched Nd:YAG laser (LFQSNY) has been widely used for treating melasma, especially in Asia. It was hard to summarize the heterogenous studies, but LFQSNY appeared to be a generally effective and safe treatment for melasma considering the results of previous conventional therapies. However, mottled hypopigmentation has been occasionally reported to develop and persist as an adverse event of LFQSNY, which may be associated with the high accumulated laser energy. When used aggressively, even LFQSNY can induce hyperpigmentation via unwanted inflammation, especially in darker skin.
Recently, the low-fluence Q-switched Nd:YAG laser (LFQSNY) has been widely used for treating melasma, especially in Asia. It was hard to summarize the heterogenous studies, but LFQSNY appeared to be a generally effective and safe treatment for melasma considering the results of previous conventional therapies. However, mottled hypopigmentation has been occasionally reported to develop and persist as an adverse event of LFQSNY, which may be associated with the high accumulated laser energy. When used aggressively, even LFQSNY can induce hyperpigmentation via unwanted inflammation, especially in darker skin.
Ana samun matsalolin pigmentation sau da yawa a cikin kulawa na farko. Nau'o'in rikice-rikice na hyperpigmentation na yau da kullun sun haɗa da post-inflammatory hyperpigmentation, melasma, sunspots, freckles, café au lait spots.
Pigmentation problems are often found in primary care. Common types of hyperpigmentation disorders include post-inflammatory hyperpigmentation, melasma, sunspots, freckles, café au lait spots.
Pigmentation problems are often found in primary care. Common types of hyperpigmentation disorders include post-inflammatory hyperpigmentation, melasma, sunspots, freckles, café au lait spots.
Melasma ba za a iya warware ta da Laser magani na wani ɗan lokaci, domin cuta ce wadda a cikinta ake ci gaba da samar da pigment. Tranxenemic acid yana taimakawa wajen inganta don rage pigmentation.
○ Magani
A wasu ƙasashe (misali Japan, Koriya), ana samun tranexamic acid na baka akan kan tebur kuma yana da tasiri. Cream ɗin melasma tare da tranexamic acid da azelaic acid na iya zama ɗan taimako.
Ana iya amfani da Hydroquinone a kai a kai don maganin hyperpigmentation, amma FDA ta dakatar da samfuran OTC masu ɗauke da hydroquinone har na 2020.
#Tranexamic acid [TRANSINO]
#Laser toning technique (low fluence QS1064 laser)
#Triluma